Prognostic value of skin perfusion alterations in cirrhotic patients with septic shock (English)
- New search for: Fernández, J.
- New search for: Fernández, J.
In:
JOURNAL OF HEPATOLOGY
;
62
, 3
;
508-509
;
2015
-
ISSN:
- Article (Journal) / Print
-
Title:Prognostic value of skin perfusion alterations in cirrhotic patients with septic shock
-
Contributors:Fernández, J. ( author )
-
Published in:JOURNAL OF HEPATOLOGY ; 62, 3 ; 508-509
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2015-01-01
-
Size:2 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.3623
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.3623 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 62, Issue 3
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 503
-
From the Editor’s Desk… March 2015| 2015
- 505
-
Do we need more nucleos(t)ide analogs for the treatment of chronic hepatitis B?Petersen, J. et al. | 2015
- 508
-
Prognostic value of skin perfusion alterations in cirrhotic patients with septic shockFernández, J. et al. | 2015
- 510
-
Should C282Y homozygotes with mild iron overload be treated?Zoller, H. / Finkenstedt, A. et al. | 2015
- 512
-
Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infectionHuang, C. F. / Dai, C. Y. / Yeh, M. L. / Huang, C. I. / Tai, C. M. / Hsieh, M. H. / Liang, P. C. / Lin, Y. H. / Hsieh, M. Y. / Yang, H. L. et al. | 2015
- 519
-
Hepatitis C virus infection increases the risk of developing peripheral arterial disease: A 9-year population-based cohort studyHsu, Y. H. / Muo, C. H. / Liu, C. Y. / Tsai, W. C. / Hsu, C. C. / Sung, F. C. / Kao, C. H. et al. | 2015
- 526
-
Two-year treatment outcome of chronic hepatitis B infection treated with besifovir vs. entecavir: Results from a multicentre studyYuen, M. F. / Ahn, S. H. / Lee, K. S. / Um, S. H. / Cho, M. / Yoon, S. K. / Lee, J. W. / Park, N. H. / Kweon, Y. O. / Sohn, J. H. et al. | 2015
- 533
-
Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infectionAgarwal, K. / Fung, S. K. / Nguyen, T. T. / Cheng, W. / Sicard, E. / Ryder, S. D. / Flaherty, J. F. / Lawson, E. / Zhao, S. / Subramanian, G. M. et al. | 2015
- 541
-
Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entryLin, L. T. / Chung, C. Y. / Hsu, W. C. / Chang, S. P. / Hung, T. C. / Shields, J. / Russell, R. S. / Lin, C. C. / Li, C. F. / Yen, M. H. et al. | 2015
- 549
-
Exploration of skin perfusion in cirrhotic patients with septic shockGalbois, A. / Bigé, N. k. / Pichereau, C. / Boëlle, P. Y. / Baudel, J. L. / Bourcier, S. / Maury, E. / Guidet, B. / Ait-Oufella, H. et al. | 2015
- 556
-
Microsteatosis may not interact with macrosteatosis in living donor liver transplantationHan, S. / Ha, S. Y. / Park, C. K. / Joh, J. W. / Kwon, C. H. / Kwon, G. Y. / Kim, G. / Gwak, M. S. / Jeong, W. K. / Ko, J. S. et al. | 2015
- 563
-
Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injuryLiu, Y. / Ji, H. / Zhang, Y. / Shen, X. / Gao, F. / He, X. / Li, G. A. / Busuttil, R. W. / Kuchroo, V. K. / Kupiec-Weglinski, J. W. et al. | 2015
- 573
-
Mouse hepatocytes and LSEC proteome reveal novel mechanisms of ischemia/reperfusion damage and protection by A2aR stimulationMandili, G. / Alchera, E. / Merlin, S. / Imarisio, C. / Chandrashekar, B. R. / Riganti, C. / Bianchi, A. / Novelli, F. / Follenzi, A. / Carini, R. et al. | 2015
- 581
-
Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytesBaxter, M. / Withey, S. / Harrison, S. / Segeritz, C. P. / Zhang, F. / Atkinson-Dell, R. / Rowe, C. / Gerrard, D. T. / Sison-Young, R. / Jenkins, R. et al. | 2015
- 590
-
Role for the endoplasmic reticulum stress sensor IRE1α in liver regenerative responsesLiu, Y. / Shao, M. / Wu, Y. / Yan, C. / Jiang, S. / Liu, J. / Dai, J. / Yang, L. / Li, J. / Jia, W. et al. | 2015
- 599
-
Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamineHealy, M. E. / Chow, J. D. / Byrne, F. L. / Breen, D. S. / Leitinger, N. / Li, C. / Lackner, C. / Caldwell, S. H. / Hoehn, K. L. et al. | 2015
- 607
-
Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinomaYeung, O. W. / Lo, C. M. / Ling, C. C. / Qi, X. / Geng, W. / Li, C. X. / Ng, K. T. / Forbes, S. J. / Guan, X. Y. / Poon, R. T. et al. | 2015
- 617
-
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre studyVitale, A. / Burra, P. / Frigo, A. C. / Trevisani, F. / Farinati, F. / Spolverato, G. / Volk, M. / Giannini, E. G. / Ciccarese, F. / Piscaglia, F. et al. | 2015
- 625
-
Inhibition of fibronectin deposition improves experimental liver fibrosisAltrock, E. / Sens, C. / Wuerfel, C. / Vasel, M. / Kawelke, N. / Dooley, S. / Sottile, J. / Nakchbandi, I. A. et al. | 2015
- 634
-
Microencapsulated human mesenchymal stem cells decrease liver fibrosis in miceMeier, R. P. / Mahou, R. / Morel, P. / Meyer, J. / Montanari, E. / Muller, Y. D. / Christofilopoulos, P. / Wandrey, C. / Gonelle-Gispert, C. / Bühler, L. H. et al. | 2015
- 642
-
Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitisHartl, J. / Ehlken, H. / Weiler-Normann, C. / Sebode, M. / Kreuels, B. / Pannicke, N. / Zenouzi, R. / Glaubke, C. / Lohse, A. W. / Schramm, C. et al. | 2015
- 647
-
Aldehyde dedydrogenase-2 plays a beneficial role in ameliorating chronic alcohol-induced hepatic steatosis and inflammation through regulation of autophagyGuo, R. / Xu, X. / Babcock, S. A. / Zhang, Y. / Ren, J. et al. | 2015
- 657
-
Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2Zhou, Y. / Llauradó, G. / Orešič, M. / Hyötyläinen, T. / Orho-Melander, M. / Yki-Järvinen, H. et al. | 2015
- 664
-
Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosisde Tayrac, M. / Roth, M. P. / Jouanolle, A. M. / Coppin, H. l. / le Gac, G. r. / Piperno, A. / Férec, C. / Pelucchi, S. / Scotet, V. / Bardou-Jacquet, E. et al. | 2015
- 673
-
S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver diseaseMartínez-Uña, M. / Varela-Rey, M. / Mestre, D. / Fernández-Ares, L. / Fresnedo, O. / Fernandez-Ramos, D. / Juan, V. G. / Martin-Guerrero, I. / García-Orad, A. / Luka, Z. et al. | 2015
- 682
-
Decreased cardiovascular and extrahepatic cancer-related mortality in treated patients with mild HFE hemochromatosisBardou-Jacquet, E. / Morcet, J. / Manet, G. / Lainé, F. / Perrin, M. l. / Jouanolle, A. M. / Guyader, D. / Moirand, R. / Viel, J. F. / Deugnier, Y. et al. | 2015
- 690
-
New imaging techniques for liver diseasesVan Beers, B. E. / Daire, J. L. / Garteiser, P. et al. | 2015
- 701
-
Outcome and management of HCV/HIV coinfection pre- and post-liver transplantation. A 2015 updateMiro, J. M. / Stock, P. / Teicher, E. / Duclos-Vallée, J. C. / Terrault, N. / Rimola, A. et al. | 2015
- 712
-
Bioinformatics and database resources in hepatologyTeufel, A. et al. | 2015
- 720
-
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver diseasePawlak, M. / Lefebvre, P. / Staels, B. et al. | 2015
- 734
-
Biallelic inactivation of protoporphyrinogen oxidase and hydroxymethylbilane synthase is associated with liver cancer in acute porphyriasSchneider-Yin, X. / van Tuyll van Serooskerken, A. M. / Siegesmund, M. / Went, P. / Barman-Aksözen, J. / Bladergroen, R. S. / Komminoth, P. / Cloots, R. H. / Winnepenninckx, V. r. / zur Hausen, A. et al. | 2015
- 739
-
The rescue of DCD rodent livers grafts: Is there HOPE?Kopp, W. H. / Wijermars, L. G. / Ringers, J. / Braat, A. E. et al. | 2015
- 739
-
Reply to: “The rescue of DCD rodent livers grafts: Is there HOPE?”Schlegel, A. / Dutkowski, P. / Clavien, P. A. et al. | 2015
- 741
-
A cut-off serum creatinine value of 1.5mg/dl for AKI – To be or not to beWong, F. / O’Leary, J. G. / Reddy, K. R. / Kamath, P. S. / Garcia-Tsao, G. / Maliakkal, B. / Subramanian, R. / Thacker, L. / Bajaj, J. et al. | 2015
- 743
-
Reply to: “A cut-off serum creatinine value of 1.5mg/dl for AKI – To be or not to be”Fagundes, C. / Barreto, R. / Rodríguez, E. / Graupera, I. / Poch, E. / Solà, E. / Fernández, J. / Ginès, P. et al. | 2015
- 746
-
Interaction between infection and hepatic encephalopathyMerli, M. / Riggio, O. et al. | 2015
- 747
-
Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCTMetussin, A. / Patanwala, I. / Cross, T. J. et al. | 2015
- 748
-
Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond the Milan criteria: A randomized controlled trialPang, Q. / Liu, C. / Zhang, J. Y. / Xu, X. S. et al. | 2015
- 750
-
Target patients for partial hepatectomy and relationship between PLT and prognosis in BCLC B HCCLei, Y. / Yee, L. W. / Ping, Z. W. et al. | 2015
- 751
-
Acute liver failure following atorvastatin dose escalation: Is there a threshold dose for idiosyncratic hepatotoxicity?Carrascosa, M. F. / Salcines-Caviedes, J. R. / Lucena, M. I. / Andrade, R. J. et al. | 2015
- ix
-
Contents| 2015
-
The 2015 International Liver CongressTM. Vienna, 50th anniversary| 2015
-
EASL Special Conference, Addressing End-Stage Liver Disease, a Multifaceted Challenge. Glasgow, United Kingdom, 2015| 2015
-
EASL Monothematic Conference, Liver Disease in Resource Limited Settings. Bucharest, Romania, 2015| 2015
-
EASL Clinical School of Hepatology Course 25: Management of Critically Ill Cirrhotic Patient. Barcelona, Spain, 2015| 2015
-
Join EASL, Take an active role in the most forward thinking and dynamic Hepatology community worldwide| 2015
-
Editorial Board| 2015
-
EASL Monothematic Conference, Autoimmune Hepatitis. London, United Kingdom, 2015| 2015